2008
DOI: 10.1016/j.tox.2007.10.015
|View full text |Cite
|
Sign up to set email alerts
|

An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
68
0

Year Published

2009
2009
2014
2014

Publication Types

Select...
8
1

Relationship

4
5

Authors

Journals

citations
Cited by 77 publications
(70 citation statements)
references
References 24 publications
2
68
0
Order By: Relevance
“…12 In the last three years, similar results were also published by other researchers. 6,11,13,14 The primary objective of this study was to determine the ability of K203 to reactivate plasma cholinesterase in tabun-poisoned rats. We characterized poisoning through the intensity of toxic signs and through the level of ChE inhibition.…”
Section: Resultsmentioning
confidence: 99%
“…12 In the last three years, similar results were also published by other researchers. 6,11,13,14 The primary objective of this study was to determine the ability of K203 to reactivate plasma cholinesterase in tabun-poisoned rats. We characterized poisoning through the intensity of toxic signs and through the level of ChE inhibition.…”
Section: Resultsmentioning
confidence: 99%
“…Therefore, the second oxime, involved into the combination, should be the oxime sufficiently effective against tabun. For our experiments, trimedoxime or the oxime K203 was chosen because trimedoxime has at least some effect against tabun-inhibited AChE (13) and the oxime K203 was found to be a promising oxime against tabun (11,19,30).…”
Section: Discussionmentioning
confidence: 99%
“…Recently, the oxime K203 [1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide] was synthesized at our Department of Toxicology (30) and its pharmacokinetics was studied (7). Based on in vitro and in vivo evaluation of its reactivating, therapeutic and neuroprotective efficacy, it was considered to be the promising oxime against tabun but not against cyclosarin and soman (11,12,14,15,16,19).…”
Section: Introductionmentioning
confidence: 99%
“…150 Many new oximes have been synthesized, and their capacities of AChE reactivation evaluated. [157][158][159][160][161][162][163][164][165][166][167][168][169][170] Figure 15 shows the structure of some of those new promising bis-pyridinium oximes. For example 1,7-heptylene-bis-N,N'-syn-2-pyridiniumaldoxime, which is 200 times more active than 2-PAM and could lead to the development of compounds able to reactivate aged phosphorylated HuAChE.…”
Section: Treatment and Antidotes For Nerve Agentsmentioning
confidence: 99%